These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20920697)

  • 21. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
    Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
    Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of community-acquired Staphylococcus aureus infections in children.
    Johnson PN; Rapp RP; Nelson CT; Butler JS; Overman S; Kuhn RJ
    Ann Pharmacother; 2007 Sep; 41(9):1361-7. PubMed ID: 17652124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim/sulfamethoxazole: The role of weight-based dosing.
    Cox KK; Alexander B; Livorsi DJ; Heintz BH
    J Infect; 2017 Dec; 75(6):486-492. PubMed ID: 28919346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess.
    Halilovic J; Heintz BH; Brown J
    J Infect; 2012 Aug; 65(2):128-34. PubMed ID: 22445732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Goldberg E; Paul M; Talker O; Samra Z; Raskin M; Hazzan R; Leibovici L; Bishara J
    J Antimicrob Chemother; 2010 Aug; 65(8):1779-83. PubMed ID: 20507860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.
    Lazzarini L; Conti E; Tositti G; de Lalla F
    J Infect; 2005 Dec; 51(5):383-9. PubMed ID: 16321649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    McDonald LC; Lauderdale TL; Lo HJ; Tsai JJ; Hung CC
    Int J STD AIDS; 2003 Jul; 14(7):473-7. PubMed ID: 12869228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
    Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
    J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis.
    Kaufman KR; Thurber KM; O'Meara JG; Langworthy DR; Kashiwagi DT
    J Clin Pharm Ther; 2016 Aug; 41(4):409-13. PubMed ID: 27193482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era.
    Mistry RD; Weisz K; Scott HF; Alpern ER
    Acad Emerg Med; 2010 Feb; 17(2):187-93. PubMed ID: 20370748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Mistry RD; Schwab SH; Treat JR
    Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections.
    Khawcharoenporn T
    J Am Board Fam Med; 2011; 24(3):331; author reply 332-3. PubMed ID: 21551408
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of initial antibiotic choice and treatment of cellulitis in the pre- and post-community-acquired methicillin-resistant Staphylococcus aureus eras.
    Wells RD; Mason P; Roarty J; Dooley M
    Am J Emerg Med; 2009 May; 27(4):436-9. PubMed ID: 19555614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric cellulitis: success of emergency department short-course intravenous antibiotics.
    Kam AJ; Leal J; Freedman SB
    Pediatr Emerg Care; 2010 Mar; 26(3):171-6. PubMed ID: 20179663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and epidemiologic characteristics as predictors of treatment failures in uncomplicated skin abscesses within seven days after incision and drainage.
    Olderog CK; Schmitz GR; Bruner DR; Pittoti R; Williams J; Ouyang K
    J Emerg Med; 2012 Oct; 43(4):605-11. PubMed ID: 22698825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hyun DY; Mason EO; Forbes A; Kaplan SL
    Pediatr Infect Dis J; 2009 Jan; 28(1):57-9. PubMed ID: 19057459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus in a private dermatology office.
    Bruce AM; Spencer JM
    J Drugs Dermatol; 2008 Aug; 7(8):751-5. PubMed ID: 18720691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
    Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.